Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Sweden / NCT04568993
Active, not recruiting Not applicable

The TriggerHappy Trial

NCT04568993 · tracked via the Priya Life Science Sweden tracker
Sponsor
Sahlgrenska University Hospital
Phase
Not applicable
Started
2020-10-01
Last updated
2026-04-24

Condition(s) studied

Trigger FingerTrigger ThumbMinimally Invasive Surgery

Investigational drug(s) / intervention(s)

Proximal phalangeal levelVolar to the MCP-joint

Proximal phalangeal level: Injection of methyl prednisone and lidocaine in the tendon sheet at the level of the proximal phalanx

Volar to the MCP-joint: Injection of methyl prednisone and lidocaine in the tendon sheet volar to the MCP-joint

Study summary

This is a prospective randomized multicenterstudy focusing on PROMs after primary corticoid injection for triggerfinger with a comparison of two different injection techniques.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:• 1. Triggering of one or more fingers and/or impaired active finger motion and/or pain during active finger motion 2. Localized tenderness volar to the MCP joint of the affected finger 3. The patient seeks treatment Exclusion Criteria: 1. Previous treatment for triggerfinger in the finger to be treated 2. Impaired function of finger due to previous trauma/infection or other condition 3. Suspicion of other cause than triggeriinger/tendovaginitis 4. Patient not able to follow instructions

Primary outcome measure(s)

  • Pain after injection — Four weeks
    Visual analouge scale (VAS), range 0-10, where 0 indicates "no pain" and 10 "maximum pain"
  • Impairment of finger motion — Four weeks
    Visual analouge scale (VAS), range 0-10, where 0 indicates "no impairment" and 10 "maximum impairment"
  • Triggering — Four weeks
    Visual analouge scale (VAS), range 0-10, where 0 indicates "no trigger phenomenon" and 10 "Trigger phenomenon all the time/ locked finger"

Trial sites (1)

FacilityCityRegionStatus
Alingsås Lasarett/ District Hospital Alingsås Sweden

More Sahlgrenska University Hospital trials in Sweden

Venous Resection in Patients Undergoing Pancreatic Surgery Starting soon
Preventive Physical Activity Intervention in Head and Neck Cancer Recruiting
VALidation of Imaging-based Liver Biomarkers in PEDiatric Patients Recruiting
CBT Treatment for Internet Gaming Disorder Starting soon
Patient-reported Pain and Symptom Relief During Three Months After Surgery for Benign Prostatic Hyperplasia Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04568993 on ClinicalTrials.gov ↗ ← All trials in Sweden